一种由酸铁纳米催化剂调节的高流动性离子储可进行瘤选择性免疫治疗
Zitong Zhu1,2, Huan Wang1, Mengmeng Liu1,2
1State Key Laboratory of Rare Earth Resource Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
Journal of the American Chemical Society
|October 14, 2025
概括
这项研究引入了酸铁纳米催化剂用于瘤治疗. 这些纳米催化剂在瘤中选择性释放离子 (Na+),触发热并增强免疫疗法.
科学领域:
- 生物医学工程
- 纳米技术
- 癌症学
背景情况:
- 通过离子干扰疗法 (IIT) 治疗瘤,离子 (Na+) 介导的热致富.
- 目前的Na+输送系统面临的挑战是,在健康组织中泄漏和透性毒性.
研究的目的:
- 开发一种用于诱导瘤选择性的Na+输送系统.
- 在癌症治疗中克服传统Na+输送系统的局限性.
主要方法:
- 使用铁酸盐 (NFPP) 纳米催化剂构建超氧化酶模拟离子储.
- 在瘤细胞中控制Na+释放的NFPP的pH导入纳米催化激活.
- 在实验室和体内评估NFPP诱导的热,氧化应激和免疫反应.
主要成果:
- 在正常细胞中,NFPP纳米催化剂的离子释放最小 (OFF状态),但在酸性瘤环境中被激活 (ON状态).
- 激活的NFPP引发了快速的Na+外流,导致细胞内Na+过载和热.
- NFPP纳米平台增强氧化应激,促进免疫反应,并提供对瘤复发的保护.
结论:
- NFPP纳米催化剂提供了一个瘤选择性平台,用于Na+介导的热和免疫疗法.
- 这种方法克服了与传统的离子输送系统相关的挑战.
- 这项研究开创了纳米催化剂调节的离子储,用于精确的离子调节癌症治疗.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


